Morgan Lewis represented Cyclerion Therapeutics in the transaction.Cyclerion Therapeutics Inc. closed a licensing agreement with Akebia Therapeutics Inc. for the development and commercialization of praliciguat, an…
Cyclerion Therapeutics’ Licensing Agreement With Akebia Therapeutics

























